William L. Macias insider trades
Open-market stock purchases and sales by William L. Macias, Chief Medical Officer at Immunovant, Inc, from SEC Form 4 filings since Jun 11, 2021.
Recent trades
No open-market trades in the last 12 months.
Companies traded
- IMVT Immunovant, Inc: 35 sales, last Feb 19, 2025